Investors and Media
Document Details
Form
Filing Date
Sep 27, 2022
Document Date
Sep 23, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
4D Molecular Therapeutics
Issuer
4D MOLECULAR THERAPEUTICS, INC.
Filer
KASAHARA NORIYUKI